Toll-like Receptor Signalling As A Cannabinoid Target In Multiple Sclerosis

Multiple Sclerosis (MS)

Key Findings

Toll-like receptors (TLRs) are the sensors of pathogen-associated molecules that trigger tailored innate immune intracellular signalling responses to initiate innate immune reactions. Data from human studies indicate that complex interplay exists between TLR signalling and Multiple Sclerosis (MS) pathogenesis.

Information and Links


Link: Toll-like Receptor Signalling As A Cannabinoid Target In Multiple Sclerosis

Year: 2017

DOI: 10.1016/j.neuropharm.2016.04.009


Ratings

(How Ratings Work)

Multiple Sclerosis (MS) — 3


Likely probability of the efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.

Drugs Used

Cannabinoids

Sativex